Location History:
- Baltimore, MD (US) (2014)
- Portland, OR (US) (2019)
Company Filing History:
Years Active: 2014-2019
Title: Larisa G Tereshchenko: Innovator in Cardiac Risk Assessment
Introduction
Larisa G Tereshchenko is a prominent inventor based in Portland, OR (US). She has made significant contributions to the field of cardiac health through her innovative methods and systems aimed at assessing the risk of ventricular tachycardia and other cardiac events. With a total of 2 patents, her work is pivotal in enhancing patient care and safety.
Latest Patents
Tereshchenko's latest patents include a "Method and system to access inapparent conduction abnormalities to identify risk of ventricular tachycardia." This invention involves receiving ECG signals from a patient, filtering these signals, and identifying a heart vector to measure its movement velocity. The method quantifies changes in the curvature of the heart vector movement to determine the risk of ventricular tachycardia. Another notable patent is titled "Methods for determining risk of ventricular arrhythmia," which analyzes three-dimensional orthogonal ECG measurements to assess a patient's risk of subsequent cardiac events based on cardiac vector values and defined risk factors.
Career Highlights
Throughout her career, Tereshchenko has worked with esteemed institutions such as The Johns Hopkins University and Beth Israel Deaconess Medical Center, Inc. Her expertise in cardiac health has positioned her as a leader in her field, contributing to advancements in medical technology and patient diagnostics.
Collaborations
Some of her notable collaborators include Ronald David Berger and Mark E Josephson. Their combined efforts have furthered the development of innovative solutions in cardiac risk assessment.
Conclusion
Larisa G Tereshchenko's contributions to cardiac health through her patents and collaborations highlight her role as a key innovator in the medical field. Her work continues to impact patient care positively and advance the understanding of cardiac risks.